Invite to Medicines Optimisation Briefing working group
Date: Wednesday 18 November 2015
Venue: RPS head office, 66-68 East Smithfield, London, E1W 1AW
Time: 11:00am – 3:00pm a light lunch will be provided
Medicines optimisation is a patient-focused approach to getting the best patient outcomes from the investment in and use of medicines. To achieve this, professionals across the health and social care system need to work collaboratively and much more closely with patients, the public, and the pharmaceutical industry.
Medicines Optimisation has taken a front seat in the current changes and developments within the wider NHS in England. It requires an enhanced level of patient centred professionalism and partnership between a clinical professional and a patient. By focusing on patients and their experiences, it may help patients to improve their outcomes, take their medicines correctly and avoid taking unnecessary medicines, as well as reducing wastage of medicines, and improving medicines safety. Ultimately medicines optimisation can help encourage patients to take ownership of their treatment.
The Royal Pharmaceutical Society is the professional leadership body for pharmacists working across all sectors of pharmacy. We have met with Royal Colleges, patient and lay representatives, health professionals and ABPI to explore what medicines optimisation means to each of these groups and how to realise this important step change in practice. With input from all these groups we have developed a guidance document (http://www.rpharms.com/medicines-safety/medicines-optimisation.asp) which provides four guiding principles and seven elements for medicines optimisation that will help healthcare professionals to support patients to get the best outcomes from their medicines use. The principles describe how healthcare professionals can enable patients to improve their quality of life and outcomes from medicines use by having a sustained focus on the need to optimise patients’ medicines.
The Centre for Pharmacy Postgraduate Education (CPPE) is funded by Health Education England to offer continuing professional development for all pharmacists and pharmacy technicians providing NHS services in England.
Over the last two years, in conjunction with CPPE and patient groups, we produced eight medicines optimisation briefings. The clinical topics were asthma, cardiovascular disease, type 2 diabetes, schizophrenia, depression, acute kidney injury, epilepsy and rheumatoid arthritis . You can view these briefings and their associated articles published in the Pharmaceutical Journal at: http://www.rpharms.com/what-we-re-working-on/medicines-optimisation.asp (on the right hand side just over half way down the page).
This year we are working in collaboration again with CPPE, relevant patient groups and other professional groups to produce a further two medicines optimisation briefings for pharmacy professionals working in all sectors. The topics are learning disabilities and eye health. We are holding a working group on Wednesday 18 Nov 2015, to provide content and input into the development of these medicines optimisation briefings.
We are seeking community, hospital and primary care pharmacists, as well as medics, nurses and patients to join us and other colleagues on 18 November to shape and influence these briefing documents. If you would like to join us as part of this working group please could you email me at [email protected].